Symbols / TNON Stock $0.60 -0.20% Tenon Medical, Inc.
TNON (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
Official websiteTenon Medical, Inc., a medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States. The company offers Catamaran SI-Joint Fusion System, an invasive inferior-posterior approach to the sacroiliac joint (SI Joint) using a titanium implant for treatment of the most common types of SI Joint disorders that cause lower back pain. It also provides Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, transfixing the SI Joint along its longitudinal axis. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2025-04-09 | init | Alliance Global Partners | — → Buy | $3 |
| 2024-11-15 | main | Maxim Group | Buy → Buy | $8 |
| 2024-08-14 | reit | Benchmark | Speculative Buy → Speculative Buy | $3 |
| 2024-04-15 | main | Benchmark | Speculative Buy → Speculative Buy | $3 |
- Executive pay rises and chairman contract extended at Tenon Medical (TNON) - Stock Titan Fri, 12 Jun 2026 21
- Tenon Medical Inc (TNON) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey Wed, 17 Jun 2026 18
- Tenon Medical, Inc. Sets Date for First Quarter 2026 Earnings - Yahoo Finance Fri, 01 May 2026 07
- Tenon Medical (NASDAQ: TNON) proposes reverse split, ratifies March 11 debt issuance - Stock Titan Fri, 12 Jun 2026 20
- Analysts Are Bullish on These Healthcare Stocks: Immunic (IMUX), Tenon Medical, Inc. (TNON) - The Globe and Mail Fri, 15 May 2026 07
- Tenon Medical Inc (TNON) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey Wed, 17 Jun 2026 18
- Tenon Medical (TNON) lowers quorum threshold and updates voting rules - Stock Titan hu, 11 Jun 2026 20
- Earnings call transcript: Tenon Medical’s Q1 2026 results show record revenue growth - Investing.com ue, 12 May 2026 07
- Nokia Shares Touch New High; What Could Be Next for the Stock - TechStock² Sun, 24 May 2026 07
- symbol__ Stock Quote Price and Forecast - CNN Fri, 12 Jan 2024 04
- Tenon Medical Inc (TNON) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey Wed, 17 Jun 2026 18
- Tenon Medical Announces Closing of Private Placement of Senior Convertible Notes Offering for Gross Proceeds of $ 4.3 Million - Yahoo Finance hu, 12 Mar 2026 07
- TNON Stock Price and Chart — NASDAQ:TNON - TradingView Wed, 18 Sep 2024 07
- Tenon(R) Medical Reports First Quarter 2026 Financial Results - The Globe and Mail ue, 12 May 2026 07
- Tenon Medical raises $4.3M to fund expansion and clinical studies - Stock Titan hu, 12 Mar 2026 07
Insider Transactions
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
3.94
+20.35%
|
3.28
+11.92%
|
2.93
+323.73%
|
0.69
|
| Operating Revenue |
|
3.94
+20.35%
|
3.28
+11.92%
|
2.93
+323.73%
|
0.69
|
| Cost Of Revenue |
|
1.59
+1.28%
|
1.57
-7.17%
|
1.69
+26.65%
|
1.33
|
| Reconciled Cost Of Revenue |
|
1.59
+1.28%
|
1.57
-7.17%
|
1.69
+26.65%
|
1.33
|
| Gross Profit |
|
2.36
+37.81%
|
1.71
+37.87%
|
1.24
+293.60%
|
-0.64
|
| Operating Expense |
|
15.15
-2.11%
|
15.48
-8.79%
|
16.97
-6.17%
|
18.08
|
| Research And Development |
|
2.15
-17.44%
|
2.60
-17.70%
|
3.16
+11.85%
|
2.83
|
| Selling General And Administration |
|
13.00
+0.99%
|
12.87
-6.74%
|
13.80
-9.51%
|
15.26
|
| Selling And Marketing Expense |
|
6.03
+17.95%
|
5.11
-24.62%
|
6.78
-13.47%
|
7.83
|
| General And Administrative Expense |
|
6.97
-10.17%
|
7.76
+10.50%
|
7.03
-5.33%
|
7.42
|
| Other Gand A |
|
6.97
-10.17%
|
7.76
+10.50%
|
7.03
-5.33%
|
7.42
|
| Total Expenses |
|
16.74
-1.80%
|
17.04
-8.64%
|
18.66
-3.92%
|
19.42
|
| Operating Income |
|
-12.79
+7.08%
|
-13.77
+12.47%
|
-15.73
+16.01%
|
-18.73
|
| Total Operating Income As Reported |
|
-12.79
+7.08%
|
-13.77
+12.47%
|
-15.73
+16.01%
|
-18.73
|
| EBITDA |
|
-12.03
+7.38%
|
-12.98
+14.21%
|
-15.13
+17.18%
|
-18.27
|
| Normalized EBITDA |
|
-12.26
+6.87%
|
-13.17
+13.95%
|
-15.30
+17.09%
|
-18.45
|
| Reconciled Depreciation |
|
0.53
-19.08%
|
0.66
+53.76%
|
0.43
+47.40%
|
0.29
|
| EBIT |
|
-12.56
+7.94%
|
-13.64
+12.35%
|
-15.56
+16.18%
|
-18.56
|
| Total Unusual Items |
|
0.24
+28.96%
|
0.18
+9.58%
|
0.17
-7.22%
|
0.18
|
| Total Unusual Items Excluding Goodwill |
|
0.24
+28.96%
|
0.18
+9.58%
|
0.17
-7.22%
|
0.18
|
| Net Income |
|
-12.56
+8.17%
|
-13.67
+12.25%
|
-15.58
+17.63%
|
-18.92
|
| Pretax Income |
|
-12.56
+8.17%
|
-13.67
+12.25%
|
-15.58
+17.63%
|
-18.92
|
| Net Non Operating Interest Income Expense |
|
0.00
+100.00%
|
-0.03
-61.90%
|
-0.02
+94.07%
|
-0.35
|
| Interest Expense Non Operating |
|
0.00
-100.00%
|
0.03
+61.90%
|
0.02
-94.07%
|
0.35
|
| Net Interest Income |
|
0.00
+100.00%
|
-0.03
-61.90%
|
-0.02
+94.07%
|
-0.35
|
| Interest Expense |
|
0.00
-100.00%
|
0.03
+61.90%
|
0.02
-94.07%
|
0.35
|
| Other Income Expense |
|
0.24
+85.83%
|
0.13
-23.95%
|
0.17
+3.09%
|
0.16
|
| Other Non Operating Income Expenses |
|
—
|
-0.06
|
—
|
-0.02
|
| Gain On Sale Of Security |
|
0.24
+28.96%
|
0.18
+9.58%
|
0.17
-7.22%
|
0.18
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-12.56
+8.17%
|
-13.67
+12.25%
|
-15.58
+17.63%
|
-18.92
|
| Net Income From Continuing Operation Net Minority Interest |
|
-12.56
+8.17%
|
-13.67
+12.25%
|
-15.58
+17.63%
|
-18.92
|
| Net Income From Continuing And Discontinued Operation |
|
-12.56
+8.17%
|
-13.67
+12.25%
|
-15.58
+17.63%
|
-18.92
|
| Net Income Continuous Operations |
|
-12.56
+8.17%
|
-13.67
+12.25%
|
-15.58
+17.63%
|
-18.92
|
| Minority Interests |
|
—
|
—
|
—
|
0.00
|
| Normalized Income |
|
-12.79
+7.68%
|
-13.86
+12.01%
|
-15.75
+17.54%
|
-19.10
|
| Net Income Common Stockholders |
|
-12.56
+8.17%
|
-13.67
+12.25%
|
-15.58
+17.63%
|
-18.92
|
| Diluted EPS |
|
-1.70
+84.90%
|
-11.26
+83.61%
|
-68.72
+63.63%
|
-188.96
|
| Basic EPS |
|
-1.70
+84.90%
|
-11.26
+83.61%
|
-68.72
+63.63%
|
-188.96
|
| Basic Average Shares |
|
7.38
+508.24%
|
1.21
+435.39%
|
0.23
+126.47%
|
0.10
|
| Diluted Average Shares |
|
7.38
+508.24%
|
1.21
+435.39%
|
0.23
+126.47%
|
0.10
|
| Diluted NI Availto Com Stockholders |
|
-12.56
+8.17%
|
-13.67
+12.25%
|
-15.58
+17.63%
|
-18.92
|
| Line Item | Trend | 2023-12-31 |
|---|---|---|
| Total Assets |
|
6.34
|
| Current Assets |
|
3.89
|
| Cash Cash Equivalents And Short Term Investments |
|
2.43
|
| Cash And Cash Equivalents |
|
2.43
|
| Other Short Term Investments |
|
0.00
|
| Receivables |
|
0.52
|
| Accounts Receivable |
|
0.52
|
| Gross Accounts Receivable |
|
0.52
|
| Allowance For Doubtful Accounts Receivable |
|
0.00
|
| Inventory |
|
0.55
|
| Raw Materials |
|
0.02
|
| Finished Goods |
|
0.53
|
| Prepaid Assets |
|
0.39
|
| Other Current Assets |
|
0.39
|
| Total Non Current Assets |
|
2.46
|
| Net PPE |
|
1.61
|
| Gross PPE |
|
1.88
|
| Accumulated Depreciation |
|
-0.27
|
| Properties |
|
0.00
|
| Machinery Furniture Equipment |
|
0.07
|
| Construction In Progress |
|
0.60
|
| Other Properties |
|
1.20
|
| Leases |
|
0.01
|
| Goodwill And Other Intangible Assets |
|
—
|
| Goodwill |
|
—
|
| Other Intangible Assets |
|
—
|
| Non Current Deferred Assets |
|
0.80
|
| Non Current Prepaid Assets |
|
0.05
|
| Total Liabilities Net Minority Interest |
|
5.57
|
| Current Liabilities |
|
3.14
|
| Payables And Accrued Expenses |
|
1.38
|
| Payables |
|
0.43
|
| Accounts Payable |
|
0.43
|
| Current Accrued Expenses |
|
0.94
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
0.33
|
| Current Debt And Capital Lease Obligation |
|
1.43
|
| Current Debt |
|
1.17
|
| Other Current Borrowings |
|
1.17
|
| Current Capital Lease Obligation |
|
0.26
|
| Total Non Current Liabilities Net Minority Interest |
|
2.43
|
| Long Term Debt And Capital Lease Obligation |
|
0.43
|
| Long Term Capital Lease Obligation |
|
0.43
|
| Other Non Current Liabilities |
|
—
|
| Preferred Securities Outside Stock Equity |
|
—
|
| Stockholders Equity |
|
0.78
|
| Common Stock Equity |
|
0.78
|
| Capital Stock |
|
0.00
|
| Common Stock |
|
0.00
|
| Preferred Stock |
|
0.00
|
| Share Issued |
|
0.33
|
| Ordinary Shares Number |
|
0.33
|
| Treasury Shares Number |
|
0.00
|
| Additional Paid In Capital |
|
55.90
|
| Retained Earnings |
|
-55.07
|
| Gains Losses Not Affecting Retained Earnings |
|
-0.05
|
| Minority Interest |
|
—
|
| Other Equity Adjustments |
|
-0.05
|
| Total Equity Gross Minority Interest |
|
0.78
|
| Total Capitalization |
|
0.78
|
| Working Capital |
|
0.75
|
| Invested Capital |
|
1.95
|
| Total Debt |
|
1.86
|
| Net Debt |
|
—
|
| Capital Lease Obligations |
|
0.68
|
| Net Tangible Assets |
|
0.78
|
| Tangible Book Value |
|
0.78
|
| Non Current Accrued Expenses |
|
2.00
|
| Preferred Stock Equity |
|
—
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-10.74
-8.78%
|
-9.88
+18.92%
|
-12.18
-1.31%
|
-12.03
|
| Cash Flow From Continuing Operating Activities |
|
-10.74
-8.78%
|
-9.88
+18.92%
|
-12.18
-1.31%
|
-12.03
|
| Net Income From Continuing Operations |
|
-12.56
+8.17%
|
-13.67
+12.25%
|
-15.58
+17.63%
|
-18.92
|
| Depreciation Amortization Depletion |
|
0.53
-19.08%
|
0.66
+53.76%
|
0.43
+47.40%
|
0.29
|
| Depreciation |
|
0.53
-19.08%
|
0.66
+53.76%
|
0.43
+47.40%
|
0.29
|
| Depreciation And Amortization |
|
0.53
-19.08%
|
0.66
+53.76%
|
0.43
+47.40%
|
0.29
|
| Other Non Cash Items |
|
—
|
—
|
—
|
1.92
|
| Stock Based Compensation |
|
1.69
-56.02%
|
3.85
-7.24%
|
4.14
+43.08%
|
2.90
|
| Provisionand Write Offof Assets |
|
0.02
-60.98%
|
0.04
|
0.00
|
—
|
| Asset Impairment Charge |
|
—
|
—
|
0.00
-100.00%
|
0.08
|
| Operating Gains Losses |
|
—
|
—
|
—
|
—
|
| Gain Loss On Investment Securities |
|
—
|
—
|
—
|
—
|
| Unrealized Gain Loss On Investment Securities |
|
—
|
—
|
0.00
+100.00%
|
-0.02
|
| Change In Working Capital |
|
-0.43
+42.90%
|
-0.75
+36.40%
|
-1.17
-168.12%
|
1.72
|
| Change In Receivables |
|
-0.85
-120.47%
|
-0.39
-33.10%
|
-0.29
-90.79%
|
-0.15
|
| Changes In Account Receivables |
|
-0.85
-120.47%
|
-0.39
-33.10%
|
-0.29
-90.79%
|
-0.15
|
| Change In Inventory |
|
-0.39
-644.23%
|
-0.05
+62.59%
|
-0.14
+38.77%
|
-0.23
|
| Change In Prepaid Assets |
|
-0.04
-119.13%
|
0.18
+160.80%
|
-0.30
-428.07%
|
-0.06
|
| Change In Payables And Accrued Expense |
|
1.13
+582.55%
|
-0.23
-8.80%
|
-0.22
-109.15%
|
2.36
|
| Change In Accrued Expense |
|
0.65
+478.95%
|
-0.17
-72.73%
|
-0.10
-104.33%
|
2.29
|
| Change In Payable |
|
0.49
+859.38%
|
-0.06
+45.30%
|
-0.12
-262.50%
|
0.07
|
| Change In Account Payable |
|
0.49
+859.38%
|
-0.06
+45.30%
|
-0.12
-262.50%
|
0.07
|
| Change In Other Current Liabilities |
|
-0.29
-12.11%
|
-0.26
-12.78%
|
-0.23
-12.38%
|
-0.20
|
| Investing Cash Flow |
|
-1.02
-450.00%
|
-0.19
-103.03%
|
6.14
+312.97%
|
-2.88
|
| Cash Flow From Continuing Investing Activities |
|
-1.02
-450.00%
|
-0.19
-103.03%
|
6.14
+312.97%
|
-2.88
|
| Net PPE Purchase And Sale |
|
-0.27
-46.77%
|
-0.19
+48.48%
|
-0.36
+57.38%
|
-0.85
|
| Purchase Of PPE |
|
-0.27
-46.77%
|
-0.19
+48.48%
|
-0.36
+57.38%
|
-0.85
|
| Capital Expenditure |
|
-0.27
-46.77%
|
-0.19
+48.48%
|
-0.36
+57.38%
|
-0.85
|
| Net Investment Purchase And Sale |
|
—
|
0.00
-100.00%
|
6.50
+419.24%
|
-2.04
|
| Purchase Of Investment |
|
—
|
0.00
+100.00%
|
-0.49
+95.13%
|
-10.12
|
| Sale Of Investment |
|
—
|
0.00
-100.00%
|
7.00
-13.41%
|
8.08
|
| Net Other Investing Changes |
|
-0.75
|
—
|
—
|
—
|
| Financing Cash Flow |
|
8.99
-36.36%
|
14.12
+124.14%
|
6.30
-55.35%
|
14.11
|
| Cash Flow From Continuing Financing Activities |
|
8.99
-36.36%
|
14.12
+124.14%
|
6.30
-55.35%
|
14.11
|
| Net Issuance Payments Of Debt |
|
—
|
0.00
-100.00%
|
1.25
|
0.00
|
| Issuance Of Debt |
|
—
|
0.00
-100.00%
|
1.25
|
0.00
|
| Repayment Of Debt |
|
—
|
—
|
—
|
0.00
|
| Long Term Debt Issuance |
|
—
|
—
|
—
|
0.00
|
| Long Term Debt Payments |
|
—
|
—
|
—
|
0.00
|
| Net Long Term Debt Issuance |
|
—
|
—
|
—
|
0.00
|
| Short Term Debt Issuance |
|
—
|
0.00
-100.00%
|
1.25
|
0.00
|
| Net Short Term Debt Issuance |
|
—
|
0.00
-100.00%
|
1.25
|
0.00
|
| Net Common Stock Issuance |
|
6.86
+3.84%
|
6.61
+24.57%
|
5.30
-62.49%
|
14.14
|
| Proceeds From Stock Option Exercised |
|
3.06
-44.01%
|
5.46
+2016.28%
|
0.26
|
0.00
|
| Net Other Financing Charges |
|
-0.93
+15.33%
|
-1.10
-115.32%
|
-0.51
-1936.00%
|
-0.03
|
| Changes In Cash |
|
-2.78
-168.43%
|
4.06
+1455.94%
|
0.26
+132.83%
|
-0.80
|
| Effect Of Exchange Rate Changes |
|
0.00
-100.00%
|
0.05
+21.05%
|
0.04
+442.86%
|
0.01
|
| Beginning Cash Position |
|
6.54
+169.15%
|
2.43
+14.04%
|
2.13
-27.01%
|
2.92
|
| End Cash Position |
|
3.76
-42.52%
|
6.54
+169.15%
|
2.43
+14.04%
|
2.13
|
| Free Cash Flow |
|
-11.02
-9.48%
|
-10.06
+19.77%
|
-12.54
+2.55%
|
-12.87
|
| Interest Paid Supplemental Data |
|
—
|
—
|
0.00
|
0.00
|
| Income Tax Paid Supplemental Data |
|
—
|
—
|
0.00
|
0.00
|
| Common Stock Issuance |
|
6.86
+3.84%
|
6.61
+24.57%
|
5.30
-62.49%
|
14.14
|
| Issuance Of Capital Stock |
|
6.86
-29.72%
|
9.76
+84.07%
|
5.30
-62.49%
|
14.14
|
| Net Preferred Stock Issuance |
|
0.00
-100.00%
|
3.15
|
0.00
|
—
|
| Preferred Stock Issuance |
|
0.00
-100.00%
|
3.15
|
0.00
|
—
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 8-K2026-06-12 View
- 8-K2026-06-11 View
- 8-K2026-05-22 View
- 10-Q2026-05-15 View
- 8-K2026-05-12 View
- 42026-05-05 View
- 42026-05-05 View
- 10-K2026-03-27 View
- 8-K2026-03-19 View
- 8-K2026-03-17 View
- 42026-03-05 View
- 8-K2026-02-27 View
- 8-K2026-02-06 View
- 42026-01-05 View
- 42026-01-05 View
- 42026-01-05 View
- 42026-01-05 View
- 42026-01-05 View
- 42026-01-05 View
- 42026-01-05 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|